1-10 of 10
Arthur Bradwell, FRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Novel M-Component Based Biomarkers On to Progression Free Survival After Treatment in Intact Immunoglobulin Multiple Myeloma.

Efstathios Koulieris, Dimitrios Maltezas, Nikolaou Eytychia, Vassiliki Bartzis, Tatianna Tzenou, Vassiliki Karali, Pessach Ilias, Katerina Sarris, Stephen Harding, Arthur Bradwell, FRCP, FRCPath, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Nikolitsa Kafasi, Panayiotis Panayiotidis, Marie-Christine Kyrtsonis
Journal: Blood
Blood (2012) 120 (21): 2927.
https://doi.org/10.1182/blood.V120.21.2927.2927
Published: 2012
Journal Articles

The Ratio of Monoclonal to Polyclonal Immunoglobulins Assessed with the Hevylite Test Predicts Prognosis, Is Superior for Monitoring the Course of the Disease and Allows Detection of Monoclonal Immunoglobulin In Patients with Normal or Subnormal Involved Immunoglobulin Isotype

Heinz Ludwig, MD, Ladan Mirbahai, Niklas Zojer, PhD, MD, Arthur Bradwell, FRCP, FRCPath, Stephen Harding, PhD
Journal: Blood
Blood (2010) 116 (21): 4038.
https://doi.org/10.1182/blood.V116.21.4038.4038
Published: 2010
Journal Articles

Heavy Chain Ratio (HLCR) IgGκ/IgGλ or IgAκ/IgAλ: Experience and Clinical Implications In Multiple Myeloma at Diagnosis and During Disease Course

Efstathios Koulieris, Marie-Christine Kyrtsonis, Nikolitsa Kafassi, Dimitris Maltezas, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, George Georgiou, Ladan Mirbahai, Panayiotis Panayiotidis, Arthur Bradwell, FRCP, FRCPath, Stephen Harding, PhD
Journal: Blood
Blood (2010) 116 (21): 5019.
https://doi.org/10.1182/blood.V116.21.5019.5019
Published: 2010
Journal Articles

Non-Clonal Serum Immunoglobulin Free Light Chains (FLC) as Markers of Overall Survival

Angela Dispenzieri, M.D., Robert Kyle, MD, Jerry A Katzmann, PhD, Dirk Larson, Shaji Kumar, MD, Graham Peter Mead, PhD, Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2010) 116 (21): 3893.
https://doi.org/10.1182/blood.V116.21.3893.3893
Published: 2010
Journal Articles

Quantification of Serum IgMκ and IgMλ In Patients with Waldenstrom's Macroglobulinemia (WM) at Diagnosis and During Disease Course; Clinical Correlations

Efstathios Koulieris, Marie-Christine Kyrtsonis, Dimitris Maltezas, Tatiana Tzenou, Ladan Mirbahai, Nikolitsa Kafassi, Vassiliki Bartzis, Maria Dimou, George Georgiou, Charis Matsouka, Gerasimos Pangalis, Panayiotis Panayiotidis, Arthur Bradwell, FRCP, FRCPath, Stephen Harding, PhD
Journal: Blood
Blood (2010) 116 (21): 3004.
https://doi.org/10.1182/blood.V116.21.3004.3004
Published: 2010
Journal Articles

Heavy/Light Chain Specific Immunoglobulin Ratios at Presentation Are Prognostic for Progression Free Survival in the IFM 2005-01 Myeloma Trial.

Herve AvetLoiseau, MD, Jean-Luc Harousseau, Philippe Moreau, MD, Claire Mathiot, Thierry Facon, Michel Attal, MD, Arthur Bradwell, FRCP, FRCPath, Stephen Harding, PhD
Journal: Blood
Blood (2009) 114 (22): 1818.
https://doi.org/10.1182/blood.V114.22.1818.1818
Published: 2009
Journal Articles

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Jerry Katzmann, PhD, Raynell Clark, Angela Dispenzieri, M.D., Robert Kyle, MD, Ola Landgren, M.D., Ph.D., Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2009) 114 (22): 1788.
https://doi.org/10.1182/blood.V114.22.1788.1788
Published: 2009
Journal Articles

Serum FLC Levels at Presentation Have Independent Prognostic Significance in CLL and Levels Above 50mg/L Identify Patients with Progressive Disease.

Guy Pratt, Stephen Harding, PhD, Chris Fegan, Chris J Pepper, David Oscier, Anne Gardiner, Roger Holder, Arthur Bradwell, FRCP, FRCPath, Graham Mead, PhD
Journal: Blood
Blood (2009) 114 (22): 2355.
https://doi.org/10.1182/blood.V114.22.2355.2355
Published: 2009
Journal Articles

Abnormal Serum IgA Kappa / IgA Lambda Ratios at Maximum Response Predict Poor Progression Free Survival in Myeloma Patients.

Heinz Ludwig, MD, Stephen Harding, PhD, Caroline Bradley, Dejan Milosavljevich, Mark T Drayson, Gareth J Morgan, J. Anthony Child, Arthur Bradwell, FRCP, FRCPath
Journal: Blood
Blood (2009) 114 (22): 4879.
https://doi.org/10.1182/blood.V114.22.4879.4879
Published: 2009
Journal Articles

Serum Free Light Chain and Serum Heavy / Light Chain Ratios Are Independently Prognostic in Multiple Myeloma Patients.

Efstathios Koulieris, Stephen Harding, PhD, Marie-Christine Kyrtsonis, Caroline Bradley, Mark T Drayson, Gareth J Morgan, J. Anthony Child, Arthur Bradwell, FRCP, FRCPath
Journal: Blood
Blood (2009) 114 (22): 4880.
https://doi.org/10.1182/blood.V114.22.4880.4880
Published: 2009